Category:
Other Preparations
CAS NO:
910463-68-2
Standard:
In-house Standards,
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog used for the management of type 2 diabetes mellitus. The structure of semaglutide allows it to have a prolonged action, requiring less frequent dosing compared to other GLP-1 receptor agonists. Semaglutide has also shown promise in the management of obesity.
Semaglutide Injection is a peptide-based pharmaceutical formulation manufactured via recombinant DNA technology. It features high-purity crystalline structure stabilized in aqueous solution for parenteral administration.